Avid Bioservices Story

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;'>AB</div>
CDMO -- USA Stock  

USD 13.95  0.14  0.99%

As many millenniums are excited about healthcare space, it is only fair to outline Avid Bioservices against current market trends. As expected, Avid Bioservices is starting to reaffirm its true potential as institutional investors are becoming more and more confident in the future outlook. Plenty of the changes of the company stock price movements has been a rough indication of what is happening in the market overall. The proof of persistent basic indicators of the company suggests a short-term price swing for institutional investors of Avid Bioservices. Avid Bioservices is scheduled to announce its earnings today. The next earnings report is expected on the 9th of March 2021.
Published over a month ago
View all stories for Avid Bioservices | View All Stories
Will Avid Bioservices (NASDAQ:CDMO) price continue to rise in January?
The company's average rating is Strong Buy from 2 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Avid Bioservices market sentiment investors' perception of the future value of Avid Bioservices. Let us look at a few aspects of Avid Bioservices technical analysis.
Using predictive technical analysis, we will analyze different prices and returns patterns and diagnose historical swings to determine the real value of Avid Bioservices. In general, we focus on analyzing Avid Bioservices stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Avid Bioservices's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Avid Bioservices's intrinsic value. In addition to deriving basic predictive indicators for Avid Bioservices, we also check how macroeconomic factors affect Avid Bioservices price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Avid Bioservices' stock price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Avid Bioservices in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Avid Bioservices. Your research has to be compared to or analyzed against Avid Bioservices' peers to derive any actionable benefits. When done correctly, Avid Bioservices' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Avid Bioservices.

How does Avid Bioservices Stands against Peers?

Analyzing Avid Bioservices competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to Avid Bioservices across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be.
Check out Avid Bioservices Competition Details

How Avid Bioservices utilizes its cash?

To perform a cash flow analysis of Avid Bioservices, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Avid Bioservices is receiving and how much cash it distributes out in a given period. The Avid Bioservices cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Avid Bioservices Net Cash Flow from Operations is quite stable at the moment as compared to the past year. The company's current value of Net Cash Flow from Operations is estimated at 7.23 Million

Acquisition or disposition of Avid Bioservices securities by Daniel Hart

Legal trades by Avid Bioservices insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Avid Bioservices insider trading alert for acquisition or disposition of common stock by Daniel Hart, Chief Financial Officer, on 4th of January 2021. This event was filed by Avid Bioservices Inc with SEC on 2021-01-04. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Closer look at Avid Bioservices Semi Deviation

Avid Bioservices has current Semi Deviation of 3.89. Semi-deviation provides a good measure of downside risk for a equity or a portfolio. It is similar to standard deviation, but it only looks at periods where the returns are less than the target or average level.

Semi-deviation is the square root of semi-variance. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.

Semi Deviation 
=  
SQRT(SV) 
 = 
3.89
SQRT = Square root notation
SV =   Avid Bioservices semi variance of returns over selected period
Let's now compare Avid Bioservices Semi Deviation to its closest peers:
CDMO
EARS
DMAC
DNLI
DRNA
CDMO3.8858298878880193
EARS1.62
DMAC3.09
DNLI2.48
DRNA2.53

Possible January turnaround of Avid Bioservices?

Avid Bioservices latest potential upside surges over 8.03. Avid Bioservices shows above-average downside volatility for the selected time horizon. We advise investors to inspect Avid Bioservices further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Avid Bioservices future alpha.

Our Final Take On Avid Bioservices

Whereas some other companies within the biotechnology industry are still a little expensive, even after the recent corrections, Avid Bioservices may offer a potential longer-term growth to institutional investors. In closing, as of the 2nd of December 2020, our primary 30 days buy vs. sell advice on the company is Hold. We believe Avid Bioservices is undervalued with very high odds of distress for the next two years.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Avid Bioservices. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com